News in Brief
Pharmacology - Apr 16
Kesimpta (ofatumumab) data at AAN showed reduction in disability progression independent of relapse activity in newly diagnosed patients with RMS
Kesimpta (ofatumumab) data at AAN showed reduction in disability progression independent of relapse activity in newly diagnosed patients with RMS
Health - Apr 15
Roche's Evrysdi continues to improve motor function and survival in babies with Type 1 Spinal Muscular Atrophy (SMA)
Roche's Evrysdi continues to improve motor function and survival in babies with Type 1 Spinal Muscular Atrophy (SMA)
wire - news in brief
« BACK
Event - 07.04.2021 
The Ship Cloths of Southern Sumatra
For many centuries, the people of southern Sumatra saw themselves as living on a ship floating between the sea and the heavens.
Event - 24.03.2021
Architecture - Event - 17.03.2021
Campus - Event - 16.03.2021
Event - 03.03.2021
Administration - Event - 09.02.2021
Event - Life Sciences - 25.01.2021
Health - Event - 01.12.2020
Campus - Event - 21.11.2020
Pharmacology - Event - 05.11.2020
Environment - Event - 20.10.2020
Event - 09.10.2020
Campus - Event - 04.10.2020
Event - Life Sciences - 21.09.2020
Life Sciences - Event - 18.09.2020
Event - 17.09.2020
Life Sciences - Event - 14.09.2020
Paleontology - Event - 11.09.2020
Event - Environment - 01.09.2020
Physics - Event - 02.07.2020
Event - 02.07.2020
Event - 12.05.2020
Event - 11.05.2020
Health - Event - 04.05.2020
Life Sciences - Event - 28.04.2020
Event - Art and Design - 28.04.2020
Computer Science - Event - 27.04.2020
Health - Event - 25.04.2020
Environment - Event - 24.04.2020
Event - 01.04.2020
Pedagogy - Event - 30.03.2020
Life Sciences - Event - 09.03.2020 
Life-Giving Potion and Maternal Elixir
Milk provides sustenance and protection and is the basis of life for all mammals just after they are born.
Event - Computer Science - 06.03.2020
Physics - Event - 24.01.2020
Event - 17.01.2020
Environment - Event - 09.01.2020
Event - Innovation - 24.12.2019
Health - Event - 13.12.2019
Innovation - Event - 10.12.2019
Event - Economics / Business - 02.12.2019
Astronomy / Space Science - Event - 26.11.2019
Event - History / Archeology - 21.11.2019
Event - 19.11.2019
Event - Physics - 16.11.2019
Event - Life Sciences - 15.11.2019
Health - Event - 08.11.2019
Social Sciences - Event - 06.11.2019 
Putting research to the real-world test
Dominik Hangartner, a political scientist at ETH Zurich, has received one of Switzerland's most prestigious science awards. The National Latsis Prize has recognised the quality of Hangartner's research on migration and its importance for public policy. We sat down with Hangartner to find out what drives him and what he finds so exciting about turning research into concrete policies.
Event - Life Sciences - 08.10.2019
Event - 04.10.2019
Event - Architecture - 01.10.2019
Event
Results 1 - 50 of 256.
For many centuries, the people of southern Sumatra saw themselves as living on a ship floating between the sea and the heavens.
Fellowship IBSA Foundation 2019, accolades to Tommaso Virgilio of IRB
The IBSA Foundation Fellowships awards five scholarships each year to young researchers from universities and research institutes around the world who have distinguished themselves for their skills a
The IBSA Foundation Fellowships awards five scholarships each year to young researchers from universities and research institutes around the world who have distinguished themselves for their skills a
![[ !! FAKE !! ] ETH Zurich's turn to unveil a new logo](/news/wire/fake_eth_zurichs_turn_to_unveil_a_new_logo-2020-epfl/image_h80.jpg){kind=logo}
Milk provides sustenance and protection and is the basis of life for all mammals just after they are born.
Dominik Hangartner, a political scientist at ETH Zurich, has received one of Switzerland's most prestigious science awards. The National Latsis Prize has recognised the quality of Hangartner's research on migration and its importance for public policy. We sat down with Hangartner to find out what drives him and what he finds so exciting about turning research into concrete policies.
News in Brief
Pharmacology - Apr 16
Kesimpta (ofatumumab) data at AAN showed reduction in disability progression independent of relapse activity in newly diagnosed patients with RMS
Kesimpta (ofatumumab) data at AAN showed reduction in disability progression independent of relapse activity in newly diagnosed patients with RMS
Health - Apr 15
Roche's Evrysdi continues to improve motor function and survival in babies with Type 1 Spinal Muscular Atrophy (SMA)
Roche's Evrysdi continues to improve motor function and survival in babies with Type 1 Spinal Muscular Atrophy (SMA)